TL;DR
Researchers are testing CAR T cell therapy, originally developed for cancer, as a potential treatment for autoimmune diseases. Early results are promising but long-term effects and safety remain uncertain. This could transform how autoimmune conditions are treated.
Initial clinical trials of CAR T cell therapy for autoimmune diseases have demonstrated promising results, with some patients experiencing significant symptom relief. This therapy, originally designed for cancer, is now being explored as a potential way to reset the immune system in conditions like multiple sclerosis and lupus, offering hope for millions of patients worldwide.
CAR T cell therapy involves modifying a patient’s immune cells to target specific disease-causing cells. Originally approved by the FDA in 2017 for certain blood cancers, it has since been adapted for autoimmune conditions in experimental trials. A recent study led by researchers at the University of Colorado and Kyverna reported that 26 patients with stiff person syndrome experienced improved mobility and reduced reliance on immunotherapies after receiving a single dose of CAR T cells, with follow-ups between four and twelve months.
The therapy works by reprogramming T cells to eliminate B cells responsible for producing harmful antibodies in autoimmune diseases. A German team reported positive results in lupus patients in 2021, and subsequent trials have expanded to other conditions, including multiple sclerosis. Patients like Jan Janisch-Hanzlik, who suffers from MS, have enrolled in these trials, motivated by the potential to significantly improve quality of life.
Why It Matters
If proven effective and safe long-term, CAR T cell therapy could revolutionize treatment for autoimmune diseases, shifting from symptom management to potential disease remission or cure. It may reduce the need for lifelong immunosuppressive drugs, which have significant side effects, and improve patient outcomes globally. However, the therapy’s risks, including immune overactivation and long-term safety, are still under investigation, making it a promising but experimental approach.
CAR T: A New Cure for Cancer, Autoimmune and Inherited Disease
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background
The success of CAR T therapy in treating certain blood cancers has paved the way for its application in autoimmune diseases. Since the FDA approved the first CAR T treatment in 2017, researchers have explored its potential beyond oncology. Early studies, including a 2021 German trial in lupus, have shown encouraging results, leading to broader clinical trials for various autoimmune conditions. These efforts are still in the experimental stage, with long-term safety and efficacy not yet established.
“I think it’s a game changer for autoimmune diseases, offering a new hope for patients who have exhausted traditional treatments.”
— Amanda Piquet, autoimmune neurologist at the University of Colorado
“Our preliminary results show significant symptom improvement in patients, with some able to discontinue other immunotherapies.”
— Research team at Kyverna
Stem Cell Therapy: A Rising Tide: How Stem Cells Are Disrupting Medicine and Transforming Lives
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
It remains unclear how long the benefits of CAR T therapy will last in autoimmune patients, what long-term side effects may emerge, and how broadly applicable the treatment will be across different autoimmune diseases. Further, the optimal dosing and patient selection criteria are still under investigation.
experimental CAR T therapy for lupus
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What’s Next
Next steps include larger, randomized clinical trials to confirm efficacy and safety, along with long-term follow-up studies. Regulatory agencies will closely monitor ongoing trials to determine whether the therapy can be approved for wider use in autoimmune conditions.
CAR T: A New Cure for Cancer, Autoimmune and Inherited Disease
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
How does CAR T cell therapy work for autoimmune diseases?
It involves modifying a patient’s T cells to target and eliminate B cells that produce harmful antibodies, potentially resetting the immune system and reducing disease activity.
What are the main risks associated with CAR T therapy in autoimmunity?
Risks include immune overactivation, cytokine release syndrome, and unknown long-term side effects. Researchers are still studying safety profiles in autoimmune applications.
When might this therapy become widely available?
If ongoing trials confirm safety and efficacy, regulatory approval could follow within several years, but it remains uncertain until larger studies are completed.
Can CAR T therapy cure autoimmune diseases?
It is too early to say whether it can cure, but it has the potential to induce long-term remission in some patients, fundamentally altering disease management.
